Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded
| Market Cap | 43.35B 6.41B 5.59B 5.15B 4.85B 9.06B 604B 9.13B 61.29B 23.8B 298B 24.07B 23.56B 1,032B | P/E 2026 * |
29.6x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 38.23B 5.66B 4.93B 4.54B 4.27B 7.99B 533B 8.05B 54.04B 20.99B 263B 21.23B 20.77B 910B | EV / Sales 2026 * |
4.75x | EV / Sales 2027 * | 4.08x |
| Free-Float |
61.07% | Yield 2026 * |
1.28% | Yield 2027 * | 1.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 5.96B | |
| -1.17% | -5.55% | +39.68% | +142.62% | 992B | |
| -2.60% | -4.31% | +51.30% | +38.95% | 564B | |
| -2.17% | -3.75% | +16.63% | +56.97% | 391B | |
| -2.90% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +12.95% | 280B | |
| -2.45% | -2.88% | +24.29% | +29.93% | 279B | |
| -1.91% | -0.87% | -41.95% | -48.26% | 196B | |
| -1.59% | -5.08% | +16.03% | +47.01% | 184B | |
| -1.90% | -2.57% | +13.56% | +57.82% | 156B | |
| Average | -1.98% | +0.41% | +18.77% | +39.39% | 374.58B | |
| Weighted average by Cap. | -2.06% | -0.49% | +27.71% | +62.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.04B 1.19B 1.04B 956M 899M 1.68B 112B 1.69B 11.37B 4.42B 55.27B 4.47B 4.37B 192B | 9.54B 1.41B 1.23B 1.13B 1.07B 1.99B 133B 2.01B 13.48B 5.24B 65.53B 5.3B 5.18B 227B |
| Net income | 1.4B 208M 181M 167M 157M 294M 19.59B 296M 1.99B 771M 9.65B 780M 763M 33.45B | 1.71B 253M 221M 203M 191M 358M 23.87B 360M 2.42B 940M 11.76B 951M 930M 40.77B |
| Net Debt | -5.12B -758M -660M -609M -573M -1.07B -71.43B -1.08B -7.24B -2.81B -35.2B -2.84B -2.78B -122B | -4.46B -660M -575M -530M -499M -933M -62.21B -939M -6.31B -2.45B -30.66B -2.48B -2.42B -106B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
